Trinity Biotech PLC
TRIB Healthcare Medical Devices
Trinity Biotech PLC’s revenue for fiscal 2025 (year ended December 2025) was $43.8 million, down 28.9% from fiscal 2024. In the quarter to March 2026, revenue grew 43.3%, EPS grew 52.1%, free cash flow grew 75.2% and total debt rose 29.9%, each against the same quarter a year earlier. Dividend growth for five consecutive years.
Follow TRIB
A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.
| Older periods | Jun '25 | Sep '25 | Dec '25 | Mar '26 | |
|---|---|---|---|---|---|
Cash and Short Term Investments |
+8 more quarters Free account |
1.55 | 1.34 | 5.14 | 2.02 |
Receivables |
10.89 | 14.49 | 11.48 | 10.51 | |
Inventory |
20.13 | 19.16 | 18.83 | 18.27 | |
Other current assets |
0.43 | 0.53 | 0.46 | 0.56 | |
Total current assets |
33.00 | 35.52 | 35.90 | 31.36 | |
Property, Plant, Equpment (Net) |
4.31 | 4.01 | 5.30 | 5.08 | |
Long-Term Investments |
0.07 | 0.04 | 0.25 | 0.18 | |
Goodwill and Intangible Assets (Total) |
55.92 | 57.81 | 56.99 | 58.64 | |
Long Term Assets (Tax, Deferred) |
3.55 | 3.55 | 3.92 | 3.92 | |
Long-term assets (Other) |
2.79 | 2.79 | 2.80 | 2.74 | |
Total non-current assets |
66.63 | 68.20 | 69.26 | 70.56 | |
Total Assets |
99.63 | 103.71 | 105.17 | 101.92 | |
Notes Payable |
0.21 | 0.21 | 0.21 | 0.21 | |
Accounts Payable |
26.49 | 30.36 | 29.70 | 29.86 | |
Current Part of Debt |
— | — | 108.02 | 110.38 | |
Current Part of Capital Lease |
2.30 | 2.13 | 2.59 | 2.57 | |
Other current liabilities |
2.53 | 1.80 | 0.69 | 0.67 | |
Total current liabilities |
31.52 | 34.49 | 141.21 | 143.68 | |
Long Term Debt (Total) |
110.05 | 114.86 | 27.17 | 26.69 | |
Long Term Tax Liability (Deferred) |
4.56 | 4.56 | 4.67 | 4.67 | |
Non-current Liabilities (Other) |
3.03 | 4.51 | 4.10 | 2.61 | |
Total non-current liabilities |
117.65 | 123.93 | 35.94 | 33.96 | |
Total liabilities |
149.17 | 158.43 | 177.15 | 177.64 | |
Additional Paid In Capital |
63.80 | 63.85 | 63.80 | 64.60 | |
Common Stock (Net) |
4.34 | 0.04 | 0.04 | 0.04 | |
Retained Earnings |
(93.66) | (98.73) | (116.17) | (120.55) | |
Treasury Stock |
24.92 | 24.92 | 24.92 | 24.92 | |
Shareholders Equity (Other) |
0.91 | 5.05 | 5.27 | 5.10 | |
Common Equity (Total) |
(49.54) | (54.71) | (71.98) | (75.73) | |
Shareholders Equity (Total) |
(49.54) | (54.71) | (71.98) | (75.73) | |
Shareholders Equity and Liabilities (Total) |
99.63 | 103.71 | 105.17 | 101.92 | |
Shares (Common) |
— | — | 19.34 | — | |
Shareholders Equity (Tangible) |
(105.46) | (112.53) | (128.97) | (134.36) | |
Net Debt |
108.51 | 113.52 | 130.05 | 135.05 | |
Total Debt |
110.05 | 114.86 | 135.19 | 137.07 |